Abstract
The uptake of Tc-99m-uptake of Tc-99m-methylene diphosphonate (MDP) on bone scintigraphy can be seen at sites other than bone in a varying number of benign and malignant conditions. Extraosseous metastatic calcifications can occur in ovarian papillary serous adenocarcinoma (PSAC). These extraosseous calcifications show Tc-99m-MDP uptake. We report a case of a female in her sixties who had a previous history of PSAC of the ovary. The patient had undergone neoadjuvant chemotherapy (NACT) followed by total abdominal hysterectomy and bilateral salpingo-oophorectomy. She also received adjuvant chemotherapy. Tc-99m-MDP bone scan was performed post chemotherapy because the patient complained of lower backache. The scan showed increased uptake in the lower thoracic and lumbar vertebral regions. However, single-photon emission computed tomography/computed tomography (CT) localizes the uptake to metastatic calcified peritoneal deposits. Further 18F-fluorodeoxyglucose positron emission tomography/CT confirmed widespread peritoneal and omental metastatic disease with increased uptake.
Keywords:
Tc-99m-MDP, metastases, ovarian papillary serous adenocarcinoma
Ethics
Informed Consent: Written informed consent has been obtained from the patient for the publication of the case.
Authorship Contributions
Concept: K.A., P.S.S.P., G.K.P., Data Collection or Processing: K.B., Analysis or Interpretation: K.B., K.A., P.S.S.P., G.K.P., Literature Search: K.B., Writing: K.B., K.A.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.
References
1Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287-299.
2Bharwani N, Reznek RH, Rockall AG. Ovarian Cancer Management: the role of imaging and diagnostic challenges. Eur J Radiol. 2011;78:41-51.
3Sharma SK, Nemieboka B, Sala E, Lewis JS, Zeglis BM. Molecular Imaging of Ovarian Cancer. J Nucl Med. 2016;57:827-833.
4Oppenheimer AG, Onyedika C, Freeman LM. MDP uptake in peritoneal carcinomatosis and Krukenberg tumors from mucinous adenocarcinoma. Clin Nucl Med. 2011;36:235-236.
5Radin AI, Youssef IM, Quimbo RD, Perone RW, Guerrieri C, Abdel-Dayem HM. Technetium-99m diphosphonate imaging of psammocarcinoma of probable ovarian origin: case report and literature review. Clin Nucl Med. 2005;30:395-399.
6Ozulker T, Ozulker F, Ozpacaci T. 99mTc-MDP and 18F-FDG uptake in calcified metastatic lesions from ovarian papillary serous adenocarcinoma. Hell J Nucl Med. 2009;12:287-288.
7Kaye J, Hayward M. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review. Australas Radiol. 2002;46:13-21.
8Agrawal K, Bhattacharya A, Harisankar CN, Abrar ML, Dhaliwal LK, Mittal BR. F-18 fluoride uptake in calcified extraosseous metastases from ovarian papillary serous adenocarcinoma. Clin Nucl Med. 2012;37:e22-e23.
